Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-29 Sale | 2025-10-31 4:38 pm | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 198,359 | $66.58 | $13,206,528 | 763,254 (Indirect Direct) | View |
| 2025-10-27 Sale | 2025-10-29 5:10 pm | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 1,641 | $65 | $106,665 | 961,613 (Indirect Direct) | View |
| 2025-10-08 Sale | 2025-10-10 5:40 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 80,000 | $54.79 | $4,383,442 | 1,058,776 (Indirect Direct) | View |
| 2025-09-05 Sale | 2025-09-08 6:06 pm | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 74,000 | $53.16 | $3,933,544 | 1,048,068 (Indirect Direct) | View |
| 2025-09-04 Sale | 2025-09-08 6:05 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 80,000 | $52.2 | $4,175,835 | 1,098,776 (Indirect Direct) | View |
| 2025-08-21 Sale | 2025-08-22 4:58 pm | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO | 42,237 | $49.48 | $2,090,081 | 421,081 (Direct) | View |
| 2025-08-20 Sale | 2025-08-22 4:46 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 26,156 | $48.82 | $1,276,927 | 5,857,223 (Indirect Direct) | View |
| 2025-08-18 Sale | 2025-08-19 7:40 pm | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO | 17,353 | $50.23 | $871,722 | 463,318 (Direct) | View |
| 2025-08-08 Sale | 2025-08-12 7:06 pm | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 300,000 | $46.37 | $13,912,443 | 916,674 (Direct) | View |
| 2025-08-07 Sale | 2025-08-11 6:29 pm | BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer | 1,000 | $45.44 | $45,440 | 141,859 (Direct) | View |
| 2025-08-07 Sale | 2025-08-11 6:12 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 80,000 | $45.84 | $3,666,949 | 1,133,090 (Indirect Direct) | View |
| 2025-08-05 Sale | 2025-08-07 4:50 pm | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 17,167 | $49 | $841,183 | 52,923 (Direct) | View |
| 2025-07-01 Sale | 2025-07-03 4:30 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 80,000 | $42.63 | $3,410,450 | 1,173,090 (Indirect Direct) | View |
| 2025-06-27 Sale | 2025-07-01 7:48 pm | BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities Illiquid Investments Sub-Master LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 3,500,000 | $44 | $154,000,000 | 18,555,375 (Indirect) | View |
| 2025-06-26 Sale | 2025-06-30 5:51 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 4,707 | $44.05 | $207,327 | 7,863 (Indirect Direct) | View |
| 2021-12-29 Purchase(A) | 2025-06-30 5:49 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 1,752 | $14.24 | $24,948 | 5,981 (Indirect Direct) | View |
| 2021-12-28 Purchase(A) | 2025-06-30 5:46 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 2,338 | $12.84 | $30,028 | 4,229 (Indirect Direct) | View |
| 2025-06-24 Sale | 2025-06-26 5:08 pm | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 100,000 | $44.23 | $4,422,800 | 963,254 (Indirect Direct) | View |
| 2025-06-10 Sale | 2025-06-11 5:00 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 4,292 | $40 | $171,680 | 39,531 (Indirect Direct) | View |
| 2025-05-19 Sale | 2025-05-20 6:06 pm | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 101,156 | $33.38 | $3,376,741 | 6,635,244 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-10 Other | 2025-10-16 5:54 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | BridgeBio Pharma LLC BridgeBio Pharma Inc. 10% Owner | 784,720 | $0 | 15,374,566 (Direct) | View |
| 2025-09-05 Exercise | 2025-09-08 6:06 pm | N/A 2033-02-20 | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 74,000 | $0 | 1,048,068 (Direct) | View |
| 2025-09-05 Exercise | 2025-09-08 6:06 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 74,000 | $11.92 | 1,048,068 (Direct) | View |
| 2025-08-16 Tax Withholding | 2025-08-19 7:40 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer | 4,781 | $51.32 | 137,078 (Direct) | View |
| 2025-08-16 Tax Withholding | 2025-08-19 7:40 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO | 21,317 | $51.32 | 463,318 (Direct) | View |
| 2025-08-16 Exercise | 2025-08-19 7:38 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 129,394 | $0 | 6,442,389 (Direct) | View |
| 2025-08-16 Tax Withholding | 2025-08-19 7:38 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 32,855 | $51.32 | 6,442,389 (Direct) | View |
Ownership | 2025-08-18 5:16 pm | N/A N/A | BridgeBio Oncology Therapeutics Inc. | BBOT | BridgeBio Pharma LLC BridgeBio Pharma Inc. 10% Owner | 0 | $0 | 13,878,554 (Direct) | View |
| 2025-08-05 Exercise | 2025-08-07 4:50 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 17,167 | $0 | 52,923 (Direct) | View |
| 2025-08-05 Exercise | 2025-08-07 4:50 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 17,167 | $16.75 | 52,923 (Direct) | View |
| 2025-06-27 Gift | 2025-06-30 5:54 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 20,000 | $0 | 1,216,674 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:13 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 15,014 | $0 | 168,696 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:12 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 15,014 | $0 | 27,014 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:10 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Cook Jennifer E. Director | 15,014 | $0 | 22,166 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:07 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director | 15,014 | $0 | 988,487 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:07 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | AGUIAR ERIC Director | 15,014 | $0 | 15,014 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:06 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director | 15,014 | $0 | 25,416 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 7:06 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 15,014 | $0 | 174,418 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:57 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | MOMTAZEE JAMES C Director | 15,014 | $0 | 103,505 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:56 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 15,014 | $0 | 1,245,099 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:56 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Hassan Fred Director | 15,014 | $0 | 34,314 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:55 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Dachille Douglas A. Director | 15,014 | $0 | 35,014 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:55 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 15,014 | $0 | 20,211 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-24 6:54 pm | N/A 2035-06-19 | BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director | 15,014 | $0 | 24,014 (Direct) | View |
| 2025-06-10 Exercise | 2025-06-11 5:00 pm | N/A 2033-06-21 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 4,292 | $0 | 39,531 (Direct) | View |
| 2025-06-10 Exercise | 2025-06-11 5:00 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 4,292 | $16.75 | 39,531 (Direct) | View |
| 2025-05-16 Tax Withholding | 2025-05-20 6:06 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 32,854 | $33.84 | 6,635,244 (Direct) | View |
| 2025-05-16 Exercise | 2025-05-20 6:06 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer | 129,392 | $0 | 6,635,244 (Direct) | View |
| 2025-05-16 Tax Withholding | 2025-05-20 5:07 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO | 21,317 | $33.84 | 501,988 (Direct) | View |
| 2025-05-16 Tax Withholding | 2025-05-20 5:05 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer | 4,780 | $33.84 | 142,859 (Direct) | View |